Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Y Lip

Showing results (1-10 of 387) with videos related to

Pageof 39
Sort By:
European Heart Journal|February 13, 2001
Lipoprotein (a) and thrombogenesis in left ventricular dysfunctionG Y Lip
Journal of the American College of Cardiology|December 1, 1995
The coagulation system is activated in idiopathic cardiomyopathyG Y Lip
Postgraduate Medical Journal|August 1, 1995
Cardioversion of atrial fibrillationG Y Lip
Lancet (London, England)|November 18, 1995
Does atrial fibrillation confer a hypercoagulable state?G Y Lip
BMJ (Clinical Research Ed.)|December 4, 1993
Anticoagulation in patients with atrial fibrillation. No consensus among doctorsG Y Lip
European Heart Journal|November 24, 1999
Assessment of risk of thromboembolism in atrial fibrillation: which patients should be anticoagulated?G Y Lip
Lancet (London, England)|March 4, 1995
Hormone replacement therapy and cardiovascular riskG Y Lip
Idrugs : the Investigational Drugs Journal|June 9, 2005
Darusentan (Abbott Laboratories)G Y Lip
The Practitioner|March 15, 2000
Atrial fibrillation in general practiceG Y Lip
Journal of Human Hypertension|August 24, 1999
Antihypertensive agents and left ventricular hypertrophy with 'usual' care in the population settingG Y Lip
Pageof 39

Showing results (1-10 of 387) with videos related to

Sort By:
Pageof 39
European Heart Journal|February 13, 2001
Lipoprotein (a) and thrombogenesis in left ventricular dysfunctionG Y Lip
Journal of the American College of Cardiology|December 1, 1995
The coagulation system is activated in idiopathic cardiomyopathyG Y Lip
Postgraduate Medical Journal|August 1, 1995
Cardioversion of atrial fibrillationG Y Lip
Lancet (London, England)|November 18, 1995
Does atrial fibrillation confer a hypercoagulable state?G Y Lip
BMJ (Clinical Research Ed.)|December 4, 1993
Anticoagulation in patients with atrial fibrillation. No consensus among doctorsG Y Lip
European Heart Journal|November 24, 1999
Assessment of risk of thromboembolism in atrial fibrillation: which patients should be anticoagulated?G Y Lip
Lancet (London, England)|March 4, 1995
Hormone replacement therapy and cardiovascular riskG Y Lip
Idrugs : the Investigational Drugs Journal|June 9, 2005
Darusentan (Abbott Laboratories)G Y Lip
The Practitioner|March 15, 2000
Atrial fibrillation in general practiceG Y Lip
Journal of Human Hypertension|August 24, 1999
Antihypertensive agents and left ventricular hypertrophy with 'usual' care in the population settingG Y Lip
Pageof 39